Mind Medicine (MindMed) Inc. Subordinate Voting Shares Stock Prediction and Forecast [MNMD]
1 extracted signal · 1 resolved · 0 still active
StockInvest.usIndependent analyst profile- Source published
- 16 Aug 2025, 03:13 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC
![Video preview for Mind Medicine (MindMed) Inc. Subordinate Voting Shares Stock Prediction and Forecast [MNMD]](https://i.ytimg.com/vi/gdiH1r6tKaY/hqdefault.jpg)
AI-generated source summary
The analysis focuses on Mind Medicine (MNMD) subordinate voting shares. Since July 9, 2025, the system has rated MNMD as "hold or accumulate", assigning a score of 0.706. From that rating the stock had remarkable gain of 24.48%, translating to a 0.87% daily return. The analysis places the stock within a robust short-term upward trend, anticipating further growth. The three-month trend shows 46.67% change with potential returns between 25.70% and 57.33%. Twelve-month forecasts suggest a 23.78% increase, fluctuating from -$28.01% to +$31.04%. This suggests a future price range of $6.92 to $12.59. The recent trading day saw a 1.13% price decrease, ending at $9.61 with a 3.83% fluctuation range, trading volume decreased, The weekly volatility is at 4.55%. The insider power showing buying action. The analysts suggest using a stop-loss at $9.05.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
StockInvest.us
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.